n/a
Conditions
Interventions
24 intranasal units (IU) of oxytocin, administered via a nasal spray containing
4 IU oxytocin per spray. In total 6 sprays of oxytocin (3 per nostril) will be
administered. Placebo (PLC) will consis
Sponsors
Radboud Universiteit Nijmegen
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 18-30 years old, male, good physical and mental health
Exclusion criteria
Exclusion criteria: • History of medication within 1 month prior to the start of treatment with trial medication with exception of occasional use of paracetamol. • Medical or surgical history that in the investigator*s view may significantly affect the outcome of the trial; such as severe visual impairment (including color-blindedness). • Febrile illness within 3 days before the first dose. • Participation in another drug study within 3 months preceding participation in the current study. • Inability to understand the nature and extent of the trial and the procedures required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main outcome-measures consist of the results of the test battery measurements including trait questionnaires and repeated measurements (state measurements) of subjective effects assessed using the Bond and Lader Mood Rating Scale. | — |
Countries
Netherlands
Outcome results
None listed